D At Its Schenectady Facility

Lewis S. Edelheit, formerly the manager of the Electronic Systems Research Center at General Electric Co., has been appointed senior vice president for corporate research and development at the GE Research and Development Center in Schenectady, N.Y. He began his new job on November 2. The longtime GE employee--he first joined the GE R&D center in 1969, after receiving his Ph.D. in physics from the University of Illinois in Urbana--specializes in the development of medical imaging scanners. Th

Written byRon Kaufman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The longtime GE employee--he first joined the GE R&D center in 1969, after receiving his Ph.D. in physics from the University of Illinois in Urbana--specializes in the development of medical imaging scanners.

The Schenectady center is one of 26 R&D facilities run by GE around the United States. In 1991, GE was issued 973 U.S. patents; of them, the R&D center accounted for 313. GE products based on inventions from the center include the "fan-beam" computed tomography scanner, synthetic industrial diamonds, and Lexan polycarbonate resin.

Edelheit says that having a vision for the future as well as quick decision-making are perhaps the most essential characteristics of a successful R&D director. "What I see as the key part of my job is getting the right people working on the right projects every day," he says. "We've got to balance off high-risk and low-risk projects; balance off near-term and short- term projects; ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies